CC
FPRX

Commodore Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Commodore Capital’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-361,344
Closed -$13.6M – 34
2021
Q1 		$13.6M Sell
361,344
-170,656
-32% -$4.26M 5.42% 5
2020
Q4 		$9.05M Buy
+532,000
New +$6.67M 4.92% 4

Commodore Capital's FPRX Position: Q2 2021 in Review

Commodore Capital sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 361,344 shares — an estimated $13.6M sold.

Commodore Capital first reported a position in FPRX in Q4 2020 and held it in 2 quarters. The position peaked at $13.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Commodore Capital reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Commodore Capital sold 361,344 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $13.6M.
  • Commodore Capital first reported a position in Five Prime Therapeutics, Inc. in Q4 2020 and held it in 2 quarters.
  • Commodore Capital's Five Prime Therapeutics, Inc. position peaked at $13.6M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Commodore Capital's 13F filing for Q2 2021, filed 16 Aug 2021.